The majority of the investigated proteins were either undetectable (M-CSF, G-CSF, GM-CSF, TGF-α and IL-8; not shown) or did not change significantly in the plasma of prostate cancer patients during their follow-up (Supplementary Figure S8). This evidence concerns the gene CSF2 and prostate cancer.